PS
UTHR icon

Pensionfund Sabic’s United Therapeutics UTHR Stock Holding History

Pensionfund Sabic’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-15,600
Closed -$1.75M – 229
2018
Q1 		$1.75M Buy
+15,600
New +$1.98M 0.5% 113
2017
Q2 		– Sell
-9,000
Closed -$1.22M – 224
2017
Q1 		$1.22M Sell
9,000
-1,200
-12% -$182K 0.38% 139
2016
Q4 		$1.46M Hold
10,200
– – 0.44% 116
2016
Q3 		$1.2M Hold
10,200
– – 0.36% 132
2016
Q2 		$1.08M Hold
10,200
– – 0.32% 139
2016
Q1 		$1.14M Sell
10,200
-3,300
-24% -$418K 0.34% 143
2015
Q4 		$2.11M Buy
13,500
+4,500
+50% +$655K 0.63% 47
2015
Q3 		$1.18M Buy
+9,000
New +$1.44M 0.37% 117

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Pensionfund Sabic's UTHR Position: Q2 2018 in Review

Pensionfund Sabic sold out of United Therapeutics (UTHR) in Q2 2018, closing a stake of 15,600 shares — an estimated $1.75M sold.

Pensionfund Sabic first reported a position in UTHR in Q3 2015 and held it in 8 quarters. The position peaked at $2.11M in Q4 2015. 374 funds tracked by Wall St. Rank hold UTHR as of Q2 2018.

  • Pensionfund Sabic reported no remaining United Therapeutics position as of Q2 2018 after selling out during the quarter.
  • Pensionfund Sabic sold 15,600 United Therapeutics shares in Q2 2018, an estimated $1.75M.
  • Pensionfund Sabic first reported a position in United Therapeutics in Q3 2015 and held it in 8 quarters.
  • Pensionfund Sabic's United Therapeutics position peaked at $2.11M in Q4 2015.
  • 374 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2018.

Based on Pensionfund Sabic's 13F filing for Q2 2018, filed 2 Jul 2018.